DEA
SBRA icon

DoubleLine ETF Adviser’s Sabra Healthcare REIT SBRA Stock Holding History

DoubleLine ETF Adviser’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
11,187
-1,751
-14% -$34.7K 0.09% 161
2026
Q1 		$249K Sell
12,938
-2,586
-17% -$50.9K 0.09% 158
2025
Q4 		$294K Buy
15,524
+695
+5% +$12.9K 0.09% 154
2025
Q3 		$276K Buy
14,829
+775
+6% +$14.5K 0.08% 143
2025
Q2 		$259K Buy
14,054
+270
+2% +$4.79K 0.08% 146
2025
Q1 		$241K Sell
13,784
-3,018
-18% -$50.9K 0.08% 159
2024
Q4 		$291K Buy
16,802
+62
+0.4% +$1.13K 0.08% 146
2024
Q3 		$312K Buy
+16,740
New +$282K 0.08% 177
2024
Q2 		– Sell
-17,551
Closed -$259K – 234
2024
Q1 		$259K Buy
17,551
+1,609
+10% +$22.3K 0.07% 186
2023
Q4 		$227K Buy
+15,942
New +$226K 0.07% 191
2023
Q2 		– Sell
-11,646
Closed -$134K – 241
2023
Q1 		$134K Buy
11,646
+1,429
+14% +$17.7K 0.06% 194
2022
Q4 		$127K Buy
+10,217
New +$130K 0.07% 190

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

DoubleLine ETF Adviser's SBRA Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Sabra Healthcare REIT (SBRA) stake by 14% in Q2 2026, selling an estimated $34.7K and leaving 11,187 shares worth $218K. The position accounts for 0.09% of the portfolio, ranked #161.

DoubleLine ETF Adviser first reported a position in SBRA in Q4 2022 and has held it in 12 quarters since. The position peaked at $312K in Q3 2024. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • DoubleLine ETF Adviser held 11,187 shares of Sabra Healthcare REIT worth $218K as of Q2 2026.
  • DoubleLine ETF Adviser sold 1,751 Sabra Healthcare REIT shares in Q2 2026, an estimated $34.7K.
  • Sabra Healthcare REIT made up 0.09% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #161 holding.
  • DoubleLine ETF Adviser first reported a position in Sabra Healthcare REIT in Q4 2022 and has held it in 12 quarters since.
  • DoubleLine ETF Adviser's Sabra Healthcare REIT position peaked at $312K in Q3 2024.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.